However, differences in T and NK cell maturation, or in PD-1 and CX3CR1 expression in spleen or tumor cells were not measurable between MDA-MB-453empty- and MDA-MB-453CX3CL1-based HTM or between the treatment groups. The gene discussed is CX3CR1; the disease is neoplasm.